We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

AI Tool Diagnoses Muscle Wasting in Head and Neck Cancer Patients from CT Scans

By MedImaging International staff writers
Posted on 18 Aug 2023
Print article
Image: AI-driven muscle mass assessment could improve care for head and neck cancer patients (Photo courtesy of Freepik)
Image: AI-driven muscle mass assessment could improve care for head and neck cancer patients (Photo courtesy of Freepik)

Head and neck cancers present a significant treatment challenge, often requiring a combination of surgery, radiation, and chemotherapy. While these treatments can be effective in curing the disease, they are also notorious for their severe side effects. A key concern is the development of sarcopenia, or muscle wasting. This condition can lead to difficulties in eating and drinking, resulting in malnutrition and a multitude of problems, including the possible need for a feeding tube, reduced quality of life, and even earlier death. Detecting sarcopenia early is essential but traditionally has been a labor-intensive process. Doctors usually assess muscle mass through computed tomography (CT) scans, either of the abdomen or the neck. Since CT scans of the neck are common in patients with head and neck cancer, they offer an opportunity for early identification and intervention for sarcopenia. However, diagnosing sarcopenia from these scans requires a specialized expert who can differentiate muscle from other tissue, a process that can take up to 10 minutes for each scan.

Researchers from Dana-Farber Cancer Institute (Boston, MA, USA) have developed an artificial intelligence (AI) tool that can quickly and accurately diagnose sarcopenia using CT scans of the neck in patients with head and neck cancer. The application of AI streamlines what is otherwise a painstaking process prone to human error, performing the assessment in just 0.15 seconds. The development process began by training the AI model using clinical records and CT scans from 420 patients. An expert manually assessed muscle mass for each patient based on the scans and calculated a skeletal muscle index (SMI) score. This data was used to train the deep learning model, and a second dataset was utilized to validate the model's performance. Impressively, the model made clinically acceptable assessments 96.2% of the time.

The tool could have broad clinical applications. Current methods often rely on body mass index (BMI) as an indicator of health decline related to treatment. However, when the team compared the effectiveness of BMI and SMI in predicting poor outcomes, they found that SMI was a superior predictor, suggesting it could become a crucial clinical tool. The introduction of AI-based assessment means that sarcopenia could be monitored frequently throughout a patient's treatment. Early detection might prompt interventions such as nutritional support, medication, or physical therapy, potentially improving overall outcomes. It could also influence treatment decisions at the outset, as understanding a patient's muscle mass might inform a tailored, perhaps gentler, treatment strategy.

“Sarcopenia is an indicator that the patient is not doing well. A real-time tool that tells us when a patient is losing muscle mass would trigger us to intervene and do something supportive to help,” said lead author Benjamin Kann, MD, a radiation oncologist in the Department of Radiation Oncology at Dana-Farber Brigham Cancer Center.

Related Links:
Dana-Farber Cancer Institute 

Gold Member
Solid State Kv/Dose Multi-Sensor
Ultrasound System
Acclarix AX9
Radiology Software
MSK Radiology
Imaging Table
Stille imagiQ2

Print article



view channel
Image: LumiGuide enables doctors to navigate through blood vessels using light instead of X-ray (Photo courtesy of Philips)

3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery

In vascular surgery, doctors frequently employ endovascular surgery techniques using tools such as guidewires and catheters, often accessing through arteries like the femoral artery. This method is known... Read more


view channel
Image: The VR visualization platform provides patients and surgeons with access to real-time 3D medical imaging (Photo courtesy of Avatar Medical)

VR Visualization Platform Creates 3D Patient Avatars from CT and MR Images in Real-Time

Surgeons and patients must currently rely on black and white medical images interpreted by radiologists. This limitation becomes more pronounced in complex surgeries, leading to issues such as patient... Read more


view channel
Image: Intravascular ultrasound provides a more accurate and specific picture of the coronary arteries (Photo courtesy of 123RF)

Intravascular Imaging Significantly Improves Outcomes in Cardiovascular Stenting Procedures

Individuals with coronary artery disease, which involves plaque accumulation in the arteries leading to symptoms like chest pain, shortness of breath, and heart attacks, often undergo a non-surgical procedure... Read more

Nuclear Medicine

view channel
Image: The PET imaging technique can noninvasively detect active inflammation before clinical symptoms arise (Photo courtesy of 123RF)

New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

Rheumatoid arthritis, the most common form of inflammatory arthritis, affects 18 million people globally. It is a complex autoimmune disease marked by chronic inflammation, leading to cartilage and bone... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.